Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase <i>Ptpn11</i> (Shp2) on malignant transformation of hematopoietic cells
Dan Xu(Wuhan University), Cheng‐Kui Qu(Emory University)
Cited by 111
Related Papers
Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment
|Cancer Cell|2016|85
Effects of a Leukemia-associated Gain-of-Function Mutation of SHP-2 Phosphatase on Interleukin-3 Signaling
|Journal of Biological Chemistry|2005|50
Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and Angiogenesis
|Journal of Biological Chemistry|2008|37
Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors
|Drug Metabolism Reviews|2018|22